Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 16:04:57 UTC 2023
by
admin
on
Sat Dec 16 16:04:57 UTC 2023
|
| Protein Type | MONOCLONAL ANTIBODY |
| Protein Sub Type | IGG1 |
| Sequence Origin | HUMAN |
| Sequence Type | COMPLETE |
| Record UNII |
J0FI6WE1QN
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
11861
Created by
admin on Sat Dec 16 16:04:57 UTC 2023 , Edited by admin on Sat Dec 16 16:04:57 UTC 2023
|
PRIMARY | |||
|
300000023252
Created by
admin on Sat Dec 16 16:04:57 UTC 2023 , Edited by admin on Sat Dec 16 16:04:57 UTC 2023
|
PRIMARY | |||
|
2465242
Created by
admin on Sat Dec 16 16:04:57 UTC 2023 , Edited by admin on Sat Dec 16 16:04:57 UTC 2023
|
PRIMARY | |||
|
J0FI6WE1QN
Created by
admin on Sat Dec 16 16:04:57 UTC 2023 , Edited by admin on Sat Dec 16 16:04:57 UTC 2023
|
PRIMARY | |||
|
C177087
Created by
admin on Sat Dec 16 16:04:57 UTC 2023 , Edited by admin on Sat Dec 16 16:04:57 UTC 2023
|
PRIMARY | |||
|
2415933-42-3
Created by
admin on Sat Dec 16 16:04:57 UTC 2023 , Edited by admin on Sat Dec 16 16:04:57 UTC 2023
|
PRIMARY | |||
|
HI-236
Created by
admin on Sat Dec 16 16:04:57 UTC 2023 , Edited by admin on Sat Dec 16 16:04:57 UTC 2023
|
PRIMARY | |||
|
J0FI6WE1QN
Created by
admin on Sat Dec 16 16:04:57 UTC 2023 , Edited by admin on Sat Dec 16 16:04:57 UTC 2023
|
PRIMARY | |||
|
Casirivimab
Created by
admin on Sat Dec 16 16:04:57 UTC 2023 , Edited by admin on Sat Dec 16 16:04:57 UTC 2023
|
PRIMARY |
| From | To |
|---|---|
| 1_22 | 1_96 |
| 2_22 | 2_96 |
| 2_147 | 2_203 |
| 2_223 | 4_214 |
| 2_264 | 2_324 |
| 1_147 | 1_203 |
| 2_370 | 2_428 |
| 3_23 | 3_88 |
| 3_134 | 3_194 |
| 4_23 | 4_88 |
| 4_134 | 4_194 |
| 1_223 | 3_214 |
| 1_229 | 2_229 |
| 1_232 | 2_232 |
| 1_264 | 1_324 |
| 1_370 | 1_428 |
| Glycosylation Type | MAMMALIAN |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_300 |
| N | 2_300 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
In blocking studies, REGN10933, REGN10987, and REGN-COV2 mediated concentration-dependent blockade of SARS-CoV-2 RBD binding to human ACE2 with IC50
values in the subnanomolar range.
IN-VITRO
IC50
|
||
|
TARGET ORGANISM->INHIBITOR |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Molecular Formula | CHEMICAL |
|
||||
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|